東昌府UPS國際快遞 東昌府UPS國際快遞聯合包裹取件 寄件網點

　UPS (NYSE:UPS) announced today that its freight forwarding operation at Changi Airport, Singapore, has received IATA CEIV Pharma Certification for pharmaceutical logistics. The certification is the first for UPS in Asia Pacific and strengthens the value proposition of UPS’s healthcare logistics offering in the region. It is a further validation of its capabilities in the safe, secure and efficient transportation of high-value pharmaceutical products.

　　IATA’s CEIV Pharma Certification is an industry certification developed by IATA, regulators and aviation industry stakeholders. It evaluates companies on a comprehensive range of criteria including management systems, facilities, e, operations and staff expertise. The certification requires companies to meet or exceed many existing pharmaceutical standards and guidelines such as IATA Temperature Control Regulations, European Union Good Distribution Practices, World Health Organisation Annex 5 Good Distribution Practices for Pharmaceutical Products and United States Pharmacopeia Standards.

　　“Pharmaceuticals are time and temperature-sensitive, re an extra amount of care throughout the transportation process. These are not typical packages, and at times life-saving deliveries as well. This certification is an affirmation of the high standards of handling and transportation that UPS’s customers in the healthcare and life sciences sector have come to rely on for their high-value shipments,” said Lim Bee Koong, Director, Healthcare Strategy, UPS Asia Pacific.

　　As a biomedical sciences hub for the Asia Pacific region, Singapore is home to eight of the top 10 pharmaceutical companies globally, manufacturing four of the top 10 drugs by global revenue2. With a third of scrapped pharmaceuticals globally attributed to logistics issues3, maintaining the integrity of the healthcare supply chain is crucial to Singapore’s biomedical manufacturing sector.

　　Enhancing its value proposition with an industry-leading set of standards like the IATA CEIV Pharma certification is part of UPS’s vision to inspire trust and empower innovation to improve patient care across the healthcare and life sciences ecosystem.